Replies to post #98846 on Cytodyn Inc (CYDY)

[dloggold]

I don’t know I’m just trying to state the facts as I know them.
I must be missing something here
I did not realize this was in stage three I had been led to believe they were in a phase two and had reported the safety data last week and plan to report the efficacy when they get it together.
I guess I’ll wait for the conference call Thursday
One thing I will say the shareholders here need to ask the hard questions
why did you unload millions of shares down here when you have a 500 dollar stock right around the corner ?
That should be question 1

[moneycrew]

Leronlimab is way beyond and way ahead of the others. No need for additional trials. Leronlimab is a done deal, we got this.

[SmileyRiley_595]

I don’t believe representatives from the White House were speaking of Lenzilumab’s support from the NIH when they said big news coming from therapeutics this week... If it was, that announcement should be met with all the negative comments I hear about letdowns from unrealistic expectations from Dr. NP’s timelines...

Furthermore, how could anyone be surprised by Lenzilumab getting NIH support when the govt has already invested so much in Remdesivir... That combo phase 3 is still a couple of months away...

One can postulate on this, that, and the other... I get it... our expectations are too high... I’m going to be pleasantly surprised if we have all the data on Thursday!!! There’s a benefit to transparency but, we’re too close to the details... You would typically never know this process so intimately... the bottom-line is that we wouldn’t be this anxious if we were not so close to the details.

Leronlimab’s results are coming and my belief that they will be statistically significant is based on the fact that Leronlimab binds to CCR5 and that is one of the most important defenses against Covid-19 among many, many other dreadful diseases!!!